Comparison of the efficacy of topical 1% lindane vs 5% permethrin in scabies: A randomized, double-blind study

Indian Journal of Dermatology, Venereology and Leprology

Volumn 72, Issue 1, 2006, Pages 33-36

  Zargari, Omid ^a,c   Golchai, Javad ^a   Sobhani, Abdolrasoul ^a   Dehpour, Ahmad R ^b   Sadr Ashkevari, Shahriar ^a   Alizadeh, Narges ^a   Darjani, Abas ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Booali Building ^*  (Iran)

Author keywords

Iran; Scabies; Treatment

Indexed keywords

LINDANE; PERMETHRIN;

ADOLESCENT; ADULT; APPLICATION SITE IRRITATION; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FAMILY; FEMALE; FOLLOW UP; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SCABIES; SKIN IRRITATION; TOPICAL TREATMENT; TREATMENT OUTCOME;

EID: 32044471499     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.19715     Document Type: Article

References (17)

1. Hernandez-Perez E. Resistance to antiscabietic drugs. J Am Acad Dermatol 1983;8:121-3.
2. Orkin M, Maibach HI. Scabies therapy-1993. Semin Dermatol 1993;12:22.
3. Cannon AB, McCrae ME. Treatment of scabies: report of one hundred patients with hexachlorocyclohexane in vanishing crème base. JAMA 1948;138:557.
4. Taplin D, Meinking TL, Porcelain SL, Castillero PM, Chen JA. Permethrin 5% dermal cream: a new treatment for scabies. J Am Acad Dermatol 1986;15:995-1001.
5. Purvis RS, Tyring SK. An outbreak of lindane-resistant scabies treated successfully with permethrin 5% cream. J Am Acad Dermatol 1991;25:1015-6.
6. Lee B, Groth P. Scabies: transcutaneous poisoning during treatment. Pediatrics 1977;59:643.
7. Davies JE, Dadhia HW, Morgade C, Barquet A, Maibach HI. Lindane poisoning. Arch Dermatol 1983;119:142-4.
8. Elgart ML. A risk benefit assessment of agents used in the treatment of scabies. Drug Safet 1996;14:386-93.
9. Burkhart CG, Burkhart CN. Optimal treatment for scabies remains undetermined. J Am Acad Dermatol 2001;45:637.
10. Taplin D, Meinking TL, Chen JA, Sanchez R. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990;7:67-73.
11. Taplin D, Meinking TL. Pyrethrins and pyrethroids in dermatology. Arch Dermatol 1990;126:213-21.
12. Franz TJ, Lehman PA, Franz SF, Guin JD. Comparative percutaneous absorption of lindane and permethrin. Arch Dermatol 1996;132:901-5.
13. Campbell WC. Ivermectin, an antiparasitic agent. Med Res Rev 1993;13:61-79.
14. Schultz MW, Gomez M, Hansen RC, Mills J, Menter A, Rodgers H, et al. Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies. Arch Dermatol 1990;126:167-70.
15. Usha V, Gopalakrishnan Nair TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000;42:236-40.
16. Elgart ML. Cost-benefit analysis of ivermectin, permethrin and benzyl benzoate in the management of infantile and childhood scabies. Expert Opin Pharmacother 2003;4:1521-4.
17. Amerio P, Capizzi R, Milani M. Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomized, investigator-blinded, comparative trial vs. permethrin cream. Eur J Dermatol 2003;13:69-71.